美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Endovia Health Sciences Inc

0.1460

-0.0100-6.41%

盘前：0.1401-0.0059-4.04%04:34 EDT

成交量：28.73万

成交额：4.22万

市值：161.76万

市盈率：-0.01

高：0.1512

开：0.1500

低：0.1400

收：0.1560

52周最高：13.40

52周最低：0.1400

股本：1,107.93万

流通股本：1,107.14万

量比：0.13

换手率：2.59%

股息：- -

股息率：- -

每股收益(TTM):-13.6011

每股收益(LYR):-70.9984

净资产收益率：--

总资产收益率：-77.70%

市净率：-0.10

市盈率(LYR):0.00

数据加载中...

总览公司新闻资讯公告

Endovia与Lupvindol Biosciences宣布FDA认定Cannepil®用于犬类骨癌疼痛属于小众用途，确立有条件批准路径资格

Endovia Health Sciences：FDA进一步裁定，将通过批准相关新兽药申请维持小众用途地位

Endovia Health Sciences于2026年9月18日与C/M Capital Master Fund签订意向书——SEC文件披露

Endovia Health Sciences 正积极评估更多大麻素配方及知识产权，寻求许可、收购与合作机会——SEC文件披露

Endovia Health Sciences欢迎联邦大麻素政策转向，推进Cannepil FDA申报，并拓展研发管线

Endovia Health Sciences：即将提交Cannepil FDA申报材料并申请会前会议——SEC文件披露

Endovia Health Sciences：首推Cannepil，聚焦伴侣动物癌症疼痛，从犬类肿瘤学起步

Endovia Health Sciences：拟依据FDA“次要用途/次要物种”认定及附条件批准途径推进研发

Endovia Health Sciences（前Splash Beverage）Cannepil®兽用开发项目达成FDA首个监管里程碑

Splash Beverage Group宣布将启用新股票代码Edva，并推出Endoviasciences.com网站——SEC文件披露

Splash Beverage Group 宣布更名：自2026年8月24日起，将正式更名为 Endovia Health Sciences

Splash Beverage Group 提交招股说明书：持股股东计划转售最多500万股

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/EDVA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EDVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","market":"US","secType":"STK","nameCN":"Endovia Health Sciences Inc","latestPrice":0.146,"timestamp":1791835200000,"preClose":0.156,"halted":0,"volume":287262,"hourTrading":{"tag":"盘前","latestPrice":0.1401,"preClose":0.146,"latestTime":"04:34 EDT","volume":4953,"amount":706.0338051,"timestamp":1791880464158,"change":-0.0059,"changeRate":-0.040411,"amplitude":0.041096},"delay":0,"changeRate":-0.06410256410256417,"floatShares":11071400,"shares":11079300,"eps":-13.601116,"marketStatus":"盘前交易","change":-0.01,"latestTime":"10-13 05:29:12 EDT","open":0.15,"high":0.1512,"low":0.14,"amount":42159.340982,"amplitude":0.071795,"askPrice":0.1789,"askSize":1749,"bidPrice":0.1336,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-13.601116,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"exchange":"AMEX","adjPreClose":0.146,"preHourTrading":{"tag":"盘前","latestPrice":0.1401,"preClose":0.146,"latestTime":"04:34 EDT","volume":4953,"amount":706.0338051,"timestamp":1791880464158,"change":-0.0059,"changeRate":-0.040411,"amplitude":0.041096},"postHourTrading":{"tag":"盘后","latestPrice":0.1429,"preClose":0.146,"latestTime":"19:35 EDT","volume":1017,"amount":146.135984,"timestamp":1791848153785,"change":-0.0031,"changeRate":-0.021233,"amplitude":0.023973},"volumeRatio":0.13485829275278782},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","floatShares":11071400,"roa":"-77.70%","roe":"--","lyrEps":-70.998368,"volumeRatio":0.13485829275278782,"shares":11079300,"dividePrice":0,"high":0.1512,"amplitude":0.071795,"preClose":0.156,"low":0.14,"week52Low":0.14,"pbRate":"-0.10","psRate":"50.41","week52High":13.3996,"institutionHeld":0,"latestPrice":0.146,"committee":-0.891833,"eps":-13.601116,"divideRate":0,"volume":287262,"delay":0,"ttmEps":-13.601116,"open":0.15,"prevYearClose":2.7616,"prevWeekClose":0.156,"prevMonthClose":0.1757,"prevQuarterClose":0.1757,"fiveDayClose":0.1659,"twentyDayClose":0.2401,"sixtyDayClose":0.3744},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-19","symbol":"EDVA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1787112000000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EDVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EDVA","date":"2026-10-12","current":-0.010734,"percent":1,"low":-0.155169,"twenty":-0.103616,"median":-0.090033,"eighty":-0.064034,"high":-0.057882,"avg":-0.088808,"sd":0.024303,"marketCap":1000353},"quantilePoints":[{"date":"2026-08-28","current":-0.118733,"twenty":-0.145082,"median":-0.136894,"eighty":-0.128751,"marketCap":2052006},{"date":"2026-09-04","current":-0.099624,"twenty":-0.136601,"median":-0.114948,"eighty":-0.105613,"marketCap":1721761},{"date":"2026-09-11","current":-0.090534,"twenty":-0.128751,"median":-0.109605,"eighty":-0.095565,"marketCap":1564655},{"date":"2026-09-18","current":-0.098697,"twenty":-0.117219,"median":-0.098326,"eighty":-0.091083,"marketCap":1705730},{"date":"2026-09-25","current":-0.070349,"twenty":-0.11379,"median":-0.094615,"eighty":-0.089265,"marketCap":1215813},{"date":"2026-10-02","current":-0.059737,"twenty":-0.111074,"median":-0.09161,"eighty":-0.073206,"marketCap":1032415},{"date":"2026-10-09","current":-0.059329,"twenty":-0.105613,"median":-0.090534,"eighty":-0.065311,"marketCap":1025362},{"date":"2026-10-12","current":-0.057882,"twenty":-0.103616,"median":-0.090033,"eighty":-0.064034,"marketCap":1000353}],"updateTime":1791883752469},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EDVA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161492507","title":"Endovia与Lupvindol Biosciences宣布FDA认定Cannepil®用于犬类骨癌疼痛属于小众用途，确立有条件批准路径资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1161492507","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161492507?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 20:46","pubTimestamp":1791204369,"startTime":"0","endTime":"0","summary":"Endovia与Lupvindol Biosciences宣布FDA认定Cannepil®用于犬类骨癌疼痛属于小众用途，确立有条件批准路径资格","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126910891","title":"Endovia Health Sciences：FDA进一步裁定，将通过批准相关新兽药申请维持小众用途地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1126910891","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126910891?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 20:46","pubTimestamp":1791204368,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences：FDA进一步裁定，将通过批准相关新兽药申请维持小众用途地位","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185625426","title":"Endovia Health Sciences于2026年9月18日与C/M Capital Master Fund签订意向书——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1185625426","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185625426?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 04:13","pubTimestamp":1790280789,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences Inc（EDVA）于2026年9月18日与C/M Capital Master Fund签署了一份意向书。根据SEC文件披露，该协议已于当日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135679679","title":"Endovia Health Sciences 正积极评估更多大麻素配方及知识产权，寻求许可、收购与合作机会——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1135679679","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135679679?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 04:11","pubTimestamp":1788207070,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新提交的文件，Endovia Health Sciences公司（股票代码：EDVA）目前不仅在推进现有业务，同时还在积极审视一系列额外的大麻素（cannabinoid）制剂及相关知识产权资产。这些评估涵盖多个维度，包括对外授权许可、潜在收购，以及战略合作等多元路径。该公司正以开放的姿态，探索多种可能性，以拓展其在这一领域的布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170636079","title":"Endovia Health Sciences欢迎联邦大麻素政策转向，推进Cannepil FDA申报，并拓展研发管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1170636079","media":"美股速递","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170636079?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 04:10","pubTimestamp":1788207011,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences对联邦层面大麻素政策的重大转变表示欢迎。该公司在提交给美国证券交易委员会的文件中披露，其正全力推进Cannepil的FDA申报工作，并同步拓展研发管线。Endovia Health Sciences积极响应该变化，并将其视为加速核心产品开发的关键契机。与此同时，Endovia Health Sciences也并未止步于单一产品。此次政策变动，加之公司自身在研发和申报上的双重发力，共同勾勒出Endovia Health Sciences在动态监管环境下主动求变、深化发展的清晰轮廓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4169","EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135316178","title":"Endovia Health Sciences：即将提交Cannepil FDA申报材料并申请会前会议——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1135316178","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135316178?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 04:10","pubTimestamp":1788207010,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences（简称EDVA）于本周向美国证券交易委员会（SEC）提交的文件中透露，计划在未来一周内递交其Cannepil产品的FDA申请，并同时请求召开一次预提交会议（Pre-Submission Conference）。这一动态标志着该公司在推进其关键候选药物监管审批道路上迈出了重要一步。据悉，预提交会议旨在通过与FDA的早期沟通，明确申报路径中的潜在问题，从而优化后续审批流程的效率和成功率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4169","EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187898799","title":"Endovia Health Sciences：首推Cannepil，聚焦伴侣动物癌症疼痛，从犬类肿瘤学起步","url":"https://stock-news.laohu8.com/highlight/detail?id=1187898799","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187898799?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 20:32","pubTimestamp":1787661162,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences公司宣布，其初期战略将锁定Cannepil这一产品，专门用于缓解伴侣动物因癌症引发的疼痛。而这一计划的起点，正是犬类肿瘤治疗领域。伴侣动物的癌症疼痛管理，长期面临方案匮乏的困境。Endovia此番入局，显然意在填补这一空白。Cannepil作为核心产品，其定位清晰：直击癌症相关疼痛，而非泛泛的镇痛市场。目前，Endovia尚未透露Cannepil的具体上市时间表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107920718","title":"Endovia Health Sciences：拟依据FDA“次要用途/次要物种”认定及附条件批准途径推进研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1107920718","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107920718?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 20:32","pubTimestamp":1787661162,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences宣布，其有意在美国食品药品监督管理局的“次要用途/次要物种”认定框架下，推动相关产品的研发工作，并计划采用该机构设定的附条件批准路径。Endovia Health Sciences尚未披露具体的候选产品细节，但明确表达了其致力于在这一特殊监管框架内，探索并推进创新疗法的坚定意向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183316075","title":"Endovia Health Sciences（前Splash Beverage）Cannepil®兽用开发项目达成FDA首个监管里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1183316075","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183316075?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 20:31","pubTimestamp":1787661071,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences（前身为Splash Beverage Group Inc.）宣布，其Cannepil®兽用开发项目已成功达成美国食品药品监督管理局（FDA）的首个监管里程碑。这一进展标志着该公司在兽用医疗领域迈出了关键一步，为其后续研发及商业化进程奠定了坚实基础。据悉，此次里程碑的达成，是Endovia Health Sciences战略转型的重要成果，也彰显了其在生命科学领域的深耕决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128381110","title":"Splash Beverage Group宣布将启用新股票代码Edva，并推出Endoviasciences.com网站——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1128381110","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128381110?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 20:56","pubTimestamp":1786539405,"startTime":"0","endTime":"0","summary":"Splash Beverage Group Inc.（股票代码：SBEV）即将迎来重大变革。根据美国证券交易委员会（SEC）提交的文件，这家公司计划更换其股票代码，采用全新的“Edva”作为标识。与此同时，企业还将同步上线一个独立域名网站——Endoviasciences.com。这一系列动作背后，或许预示着公司战略重心的转移或业务版图的扩张。市场对此消息反应如何？后续发展值得关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169","BK4113","SBEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113650280","title":"Splash Beverage Group 宣布更名：自2026年8月24日起，将正式更名为 Endovia Health Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=1113650280","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113650280?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 20:43","pubTimestamp":1786538589,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，Splash Beverage Group Inc.（股票代码：SBEV）正式对外宣布，公司即将迎来一次重大品牌重塑。从2026年8月24日起，这家公司将以全新的名称——“Endovia Health Sciences” 亮相资本市场。此项更名决定，标志着公司战略方向的一次关键转变，从传统的饮料领域向健康科学领域拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4169","BK4113","SBEV","EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169976339","title":"Splash Beverage Group 提交招股说明书：持股股东计划转售最多500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1169976339","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169976339?lang=zh_cn&edition=fundamental","pubTime":"2026-08-08 04:06","pubTimestamp":1786133174,"startTime":"0","endTime":"0","summary":"Splash Beverage Group 已向美国证券交易委员会（SEC）提交了一份招股说明书。该文件显示，公司的一位持股股东计划转售最多500万股股份。这一举动通常意味着现有股东希望套现，而非公司直接发行新股以筹集资金。不过，此类文件仍需经历SEC的审核流程，最终是否实施及具体数量仍存变数。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBEV","EDVA","BK4169","BK4113"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}